Skip to main content

Advertisement

Log in

The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Fatigue is a substantial problem in patients with psoriatic arthritis (PsA) that needs to be considered in the core set of domains. This study aimed to evaluate fatigue and its relationship with disease parameters, functional disability, anxiety, depression, quality of life, and correlation with disease activity as determined by various scales. A total of 1028 patients (677 females, 351 males) with PsA who met the CASPAR criteria were included [Turkish League Against Rheumatism (TLAR) Network multicenter study]. The demographic features and clinical conditions of the patients were recorded. Correlations between fatigue score and clinical parameters were evaluated using the Disease Activity Score 28 (DAS28), Disease Activity in Psoriatic Arthritis (DAPSA), Clinical DAPSA (cDAPSA), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Fibromyalgia Rapid Screening Tool (FiRST), minimal disease activity (MDA), and very low disease activity (VLDA). Fatigue was assessed with the Functional Assessment of Chronic Illness Therapy (FACIT-F) and a 10-point VAS (VAS-F). The mean age of the patients was 47 (SD: 12.2) years, and the mean disease duration was 6.4 (SD: 7.3) years. The mean VAS-F score was 5.1 (SD: 2.7), with fatigue being absent or mild, moderate, and severe in 12.8%, 24.6%, and 62.5% of the patients, respectively. Fatigue scores were significantly better in patients with DAS28 remission, DAPSA remission, cDAPSA remission, MDA, and VLDA (p < 0.001). Fatigue scores significantly increased with increasing disease activity levels on the DAS28, DAPSA, and cDAPSA (p < 0.001). VAS-F scores showed correlations with the scores of the BASDAI, BASFI, PsAQoL, HAD-A, FiRST, pain VAS, and PtGA. FiRST scores showed fibromyalgia in 255 (24.8%) patients. FACIT-F and VAS-F scores were significantly higher in patients with fibromyalgia (p < 0.001). In regression analysis, VLDA, BASDAI score, FiRST score, high education level, HAD-Anxiety, and BMI showed independent associations with fatigue. Our findings showed that fatigue was a common symptom in PsA and disease activity was the most substantial predictor, with fatigue being less in patients in remission, MDA, and VLDA. Other correlates of fatigue were female gender, educational level, anxiety, quality of life, function, pain, and fibromyalgia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Coates LC, Helliwell PS (2017) Psoriatic arthritis state of the art review. Clin Med 17:65–70. https://doi.org/10.7861/clinmedicine.17-1-65

    Article  Google Scholar 

  2. Nikolaus S, Bode C, Taal E, van de Laar MA (2013) Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res 65:1128–1146. https://doi.org/10.1002/acr.21949

    Article  Google Scholar 

  3. Tsutsui H, Kikuchi H, Oguchi H, Nomura K, Ohkuba T (2020) Identification of physical and psychosocial problems based on symptoms in patients with Behçet’s disease. Rheumatol Int 40:81–89. https://doi.org/10.1007/s00296-019-04488-1

    Article  PubMed  Google Scholar 

  4. Carneiro C, Chaves M, Verardino G, Frade AP, Coscarelli PG, Bianchi WA, Ramos ESM, Carneiro S (2017) Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis. Clin Cosmet Investig Dermatol 10:155–163. https://doi.org/10.2147/CCID.S124886

    Article  PubMed  PubMed Central  Google Scholar 

  5. Husted JA, Tom BD, Schentag CT, Farewell VT, Gladman DD (2009) Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis 68:1553–1558. https://doi.org/10.1136/ard.2008.098202

    Article  CAS  PubMed  Google Scholar 

  6. Dupond JL (2011) Fatigue in patients with rheumatic diseases. Joint Bone Spine 78:156–160. https://doi.org/10.1016/j.jbspin.2010.05.002

    Article  PubMed  Google Scholar 

  7. Boksem MA, Tops M (2008) Mental fatigue: costs and benefits. Brain Res Rev 59:125–139. https://doi.org/10.1016/j.brainresrev.2008.07.001

    Article  PubMed  Google Scholar 

  8. Morris G, Berk M, Galecki P, Walder K, Maes M (2016) The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol 53:1195–1219. https://doi.org/10.1007/s12035-015-9090-9

    Article  CAS  PubMed  Google Scholar 

  9. Davies K, Mirza K, Tarn J, Howard-Tripp N, Bowman SJ, Lendrem D, Ng WF (2019) Fatigue in Primary Sjogren's Syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study. Rheumatol Int 39:1867–1873. https://doi.org/10.1007/s00296-019-04354-0

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sandikci SC, Ozbalkan Z (2015) Fatigue in rheumatic diseases. Eur J Rheumatol 2:109–113. https://doi.org/10.5152/eurjrheum.2015.0029

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kalyoncu U, Bayindir Ö, Ferhat Öksüz M, Doğru A, Kimyon G, Tarhan EF, Erden A, Yavuz Ş, Can M, Çetin GY, Kılıç L, Küçükşahin O, Omma A, Ozisler C, Solmaz D, Bozkirli EDE, Akyol L, Pehlevan SM, Gunal EK, Arslan F, Yılmazer B, Atakan N, Aydın SZ (2016) The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients. Rheumatology 56:279–286. https://doi.org/10.1093/rheumatology/kew375

    Article  PubMed  Google Scholar 

  12. Gorlier C, Puyraimond-Zemmour D, Kiltz U, Orbai A-M, Leung YY, Palominos P, Cañete JD, Scrivo R, Balanescu A, Dernis E, Talli S, Ruyssen-Witrand A, Soubrier M, Aydin S, Eder L, Gaydukova I, Lubrano E, Coates L, Kalyoncu U, Smolen J, De Wit M, Gossec L (2018) SAT0318 Do patients in remission in psoriatic arthritis, have less fatigue? And does this depend on the definition of remission? An analysis of 304 patients. Ann Rheum Dis 77:1023–1024. https://doi.org/10.1136/annrheumdis-2018-eular.3106

    Article  Google Scholar 

  13. Tucker LJ, Coates LC, Helliwell PS (2019) Assessing disease activity in Psoriatic Arthritis: a literature review. Rheumatol Ther 6:23–32. https://doi.org/10.1007/s40744-018-0132-4

    Article  Google Scholar 

  14. Mease PJ, Kavanaugh A, Coates LC, McInnes IB, Hojnik M, Zhang Y, Anderson JK, Dorr AP, Gladman DD (2017) Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial. RMD Open 3:e000415. https://doi.org/10.1136/rmdopen-2016-000415

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wolfe F, Hawley DJ, Wilson K (1996) The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 23:1407–1417

    CAS  PubMed  Google Scholar 

  16. Marques M, De Gucht V, Leal I, Maes S (2013) A cross-cultural perspective on psychological determinants of chronic fatigue syndrome: a comparison between a Portuguese and a Dutch patient sample. Int J Behav Med 20:229–238. https://doi.org/10.1007/s12529-012-9265-y

    Article  CAS  PubMed  Google Scholar 

  17. Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M, Carton L, Otsa K, Sooaar I, Heiberg T, Bertheussen H, Canete JD, Sanchez Lombarte A, Balanescu A, Dinte A, de Vlam K, Smolen JS, Stamm T, Niedermayer D, Bekes G, Veale D, Helliwell P, Parkinson A, Luger T, Kvien TK (2014) A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 73:1012–1019. https://doi.org/10.1136/annrheumdis-2014-205207

    Article  PubMed  Google Scholar 

  18. Orbai AM, de Wit M, Mease PJ, Callis Duffin K, Elmamoun M, Tillett W, Campbell W, FitzGerald O, Gladman DD, Goel N, Gossec L, Hoejgaard P, Leung YY, Lindsay C, Strand V, van der Heijde DM, Shea B, Christensen R, Coates L, Eder L, McHugh N, Kalyoncu U, Steinkoenig I, Ogdie A (2017) Updating the Psoriatic Arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016. J Rheumatol 44:1522–1528. https://doi.org/10.3899/jrheum.160904.C1

    Article  PubMed  PubMed Central  Google Scholar 

  19. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673. https://doi.org/10.1002/art.21972

    Article  Google Scholar 

  20. Cheng CY, Chou YH, Wang P, Tsai JM, Liou SR (2015) Survey of trend and factors in perinatal maternal fatigue. Nurs Health Sci 17:64–70. https://doi.org/10.1111/nhs.12149

    Article  CAS  PubMed  Google Scholar 

  21. Yang S, Chu S, Gao Y, Ai Q, Liu Y, Li X, Chen N (2019) A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis. Cells 8:738. https://doi.org/10.3390/cells8070738

    Article  CAS  PubMed Central  Google Scholar 

  22. Tälli S, Etcheto A, Fautrel B, Balanescu A, Braun J, Cañete JD, de Vlam K, de Wit M, Heiberg T, Helliwell P, Kalyoncu U, Kiltz U, Maccarone M, Niedermayer D, Otsa K, Scrivo R, Smolen JS, Stamm T, Veale DJ, Kvien TK, Gossec L (2016) Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study. Joint Bone Spine 83:335–340. https://doi.org/10.1016/j.jbspin.2015.06.018

    Article  PubMed  Google Scholar 

  23. Kucukdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A (2004) Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 51:14–19. https://doi.org/10.1002/art.20091

    Article  PubMed  Google Scholar 

  24. Karatepe AG, Akkoc Y, Akar S, Kirazli Y, Akkoc N (2005) The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity. Rheumatol Int 25:612–618. https://doi.org/10.1007/s00296-004-0481-x

    Article  PubMed  Google Scholar 

  25. McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ (2004) Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 63:162–169. https://doi.org/10.1136/ard.2003.006296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

    Article  CAS  PubMed  Google Scholar 

  27. Celiker R, Altan L, Rezvani A, Aktas I, Tastekin N, Dursun E, Dursun N, Sarıkaya S, Ozdolap S, Akgun K, Zateri C, Birtane M (2017) Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST). J Phys Ther Sci 29:340–344. https://doi.org/10.1589/jpts.29.340

    Article  PubMed  PubMed Central  Google Scholar 

  28. Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, Nurre L (1996) The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 106:183–186

    Article  CAS  Google Scholar 

  29. Khallaf MK, AlSergany MA, El-Saadany HM, Abo El-Hawa MA, Ahmed RAM (2019) Assessment of fatigue and functional impairment in patients with rheumatic diseases. Egypt Rheumatol 42:51–56. https://doi.org/10.1016/j.ejr.2019.04.009

    Article  Google Scholar 

  30. Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79–79. https://doi.org/10.1186/1477-7525-1-79

    Article  PubMed  PubMed Central  Google Scholar 

  31. Piper BF, Cella D (2010) Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Canc Netw 8:958–966. https://doi.org/10.6004/jnccn.2010.0070

    Article  PubMed  Google Scholar 

  32. Helliwell PS, FitzGerald O, Fransen J (2014) Composite disease activity and responder indices for Psoriatic Arthritis: a report from the GRAPPA 2013 Meeting on development of cut-offs for both disease activity states and response. J Rheumatol 41:1212–1217. https://doi.org/10.3899/jrheum.140172

    Article  PubMed  Google Scholar 

  33. Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS (2010) Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69:1441–1447. https://doi.org/10.1136/ard.2009.122259

    Article  PubMed  Google Scholar 

  34. Lubrano E, De Socio A, Perrotta FM (2017) Comparison of composite indices tailored for Psoriatic Arthritis treated with csDMARD and bDMARD: a cross-sectional analysis of a longitudinal cohort. J Rheumatol 44:1159–1164. https://doi.org/10.3899/jrheum.170112

    Article  PubMed  Google Scholar 

  35. Schoels MM, Aletaha D, Alasti F, Smolen JS (2016) Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis 75:811–818. https://doi.org/10.1136/annrheumdis-2015-207507

    Article  PubMed  Google Scholar 

  36. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291

    CAS  Google Scholar 

  37. Coates LC, Fransen J, Helliwell PS (2010) Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69:48–53. https://doi.org/10.1136/ard.2008.102053

    Article  CAS  PubMed  Google Scholar 

  38. Coates LC, Rahman P, Psaradellis E, Rampakakis E, Osborne B, Lehman AJ, Nantel F (2019) Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab. Rheumatology (Oxford) 58:522–526. https://doi.org/10.1093/rheumatology/key359

    Article  Google Scholar 

  39. Bergman MJ, Shahouri SH, Shaver TS, Anderson JD, Weidensaul DN, Busch RE, Wang S, Wolfe F (2009) Is fatigue an inflammatory variable in rheumatoid arthritis (RA)? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia. J Rheumatol 36:2788–2794. https://doi.org/10.3899/jrheum.090561

    Article  PubMed  Google Scholar 

  40. Overman CL, Kool MB, Da Silva JA, Geenen R (2016) The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol 35:409–415. https://doi.org/10.1007/s10067-015-3035-6

    Article  PubMed  Google Scholar 

  41. Gudu T, Etcheto A, de Wit M, Heiberg T, Maccarone M, Balanescu A, Balint PV, Niedermayer DS, Canete JD, Helliwell P, Kalyoncu U, Kiltz U, Otsa K, Veale DJ, de Vlam K, Scrivo R, Stamm T, Kvien TK, Gossec L (2016) Fatigue in psoriatic arthritis—a cross-sectional study of 246 patients from 13 countries. Joint Bone Spine 83:439–443. https://doi.org/10.1016/j.jbspin.2015.07.017

    Article  PubMed  Google Scholar 

  42. Skougaard M, Jørgensen TS, Rifbjerg-Madsen S, Coates LC, Egeberg A, Amris K, Dreyer L, Højgaard P, Guldberg-Møller J, Merola JF, Frederiksen P, Gudbergsen H, Kristensen LE (2019) Relationship between fatigue and inflammation, disease duration, and chronic pain in Psoriatic Arthritis: an observational DANBIO Registry Study. J Rheumatol 47:548–552. https://doi.org/10.3899/jrheum.181412

    Article  CAS  PubMed  Google Scholar 

  43. Husted JA, Tom BD, Farewell VT, Gladman DD (2010) Longitudinal analysis of fatigue in psoriatic arthritis. J Rheumatol 37:1878–1884. https://doi.org/10.3899/jrheum.100179

    Article  PubMed  Google Scholar 

  44. Minnock P, Kirwan J, Veale D, Fitzgerald O, Bresnihan B (2010) Fatigue is an independent outcome measure and is sensitive to change in patients with psoriatic arthritis. Clin Exp Rheumatol 28:401–404

    PubMed  Google Scholar 

  45. Tobin AM, Sadlier M, Collins P, Rogers S, FitzGerald O, Kirby B (2017) Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study. Br J Dermatol 176:827–828. https://doi.org/10.1111/bjd.15258

    Article  CAS  PubMed  Google Scholar 

  46. Jørgensen TS, Skougaard M, Ballegaard C, Mease P, Strand V, Dreyer L, Kristensen LE (2018) THU0332 Fatigue remains a dominatng symptom despite tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study. Ann Rheum Dis 77:384–385. https://doi.org/10.1136/annrheumdis-2018-eular.6780

    Article  Google Scholar 

  47. Mueller C, Lin JC, Thannickal HH, Daredia A, Denney TS, Beyers R, Younger JW (2020) No evidence of abnormal metabolic or inflammatory activity in the brains of patients with rheumatoid arthritis: results from a preliminary study using whole-brain magnetic resonance spectroscopic imaging (MRSI). Clin Rheumatol 39:1765–1774. https://doi.org/10.1007/s10067-019-04923-5

    Article  PubMed  PubMed Central  Google Scholar 

  48. Druce K, McBeth J (2019) Central sensitization predicts greater fatigue independently of musculoskeletal pain. Rheumatology (Oxford) 58:1923–1927. https://doi.org/10.1093/rheumatology/kez028

    Article  Google Scholar 

  49. Magrey MN, Antonelli M, James N, Khan MA (2013) High frequency of fibromyalgia in patients with psoriatic arthritis: a pilot study. Arthritis 2013:1–4. https://doi.org/10.1155/2013/762921

    Article  Google Scholar 

  50. Ulus Y, Akyol Y, Bilgici A, Kuru Ö (2019) the impact of the presence of fibromyalgia on fatigue in patients with psoriatic arthritis: comparison with controls. Adv Rheumatol 60:1. https://doi.org/10.1186/s42358-019-0104-6

    Article  PubMed  Google Scholar 

  51. Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E (2016) Role of sleep disturbance, depression, obesity, and physical inactivity in fatigue in Rheumatoid Arthritis. Arthritis Care Res 68:81–90. https://doi.org/10.1002/acr.22577

    Article  Google Scholar 

  52. Hewlett S, Chalder T, Choy E, Cramp F, Davis B, Dures E, Nicholls C, Kirwan J (2011) Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatology (Oxford) 50:1004–1006. https://doi.org/10.1093/rheumatology/keq282

    Article  Google Scholar 

  53. Geenen R, Overman CL, Christensen R, Asenlof P, Capela S, Huisinga KL, Husebo MEP, Koke AJA, Paskins Z, Pitsillidou IA, Savel C, Austin J, Hassett AL, Severijns G, Stoffer-Marx M, Vlaeyen JWS, Fernandez-de-Las-Penas C, Ryan SJ, Bergman S (2018) EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77:797–807. https://doi.org/10.1136/annrheumdis-2017-212662

    Article  PubMed  Google Scholar 

  54. Wolfe F (2004) Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheumatol 31:1896–1902

    PubMed  Google Scholar 

Download references

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception, design and data collection. Material preparation and analysis were performed by MTD, HHG, and KN. The first draft of the manuscript was written by MTD and HHG and all authors commented on previous versions of the manuscript. All co-authors are fully responsible for all aspects of the study and the final manuscript in line with the IJME four criteria.

Corresponding author

Correspondence to Halise Hande Gezer.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Ethics approval

All procedures performed in studies involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical approval was taken from the Sakarya University Ethics Committee on 25.01.2018. The protocol number was 42. The protocol for the research project has been approved by the relevant Ethics Committee and conducted in accordance with the Helsinki Declaration.

Informed consent

Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duruöz, M.T., Gezer, H.H., Nas, K. et al. The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network. Rheumatol Int 40, 1803–1815 (2020). https://doi.org/10.1007/s00296-020-04628-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-020-04628-y

Keywords

Navigation